How best to exploit the opportunity presented by Oxyglobin without jeopardizing the potential of Hemopure is a tough problem for Biopure’s executive. According to the financial analysis‚ it is suggested that Biopure begin to sell Oxyglobin at $150 per unit to emergency care practice at the Veterinary Blood Market and have its own distribution network. This will make a profit of $5 million at first year and $17 million thereafter. The steadfast income will consolidate Biopure’s financial structure
Premium Blood Marketing Economics
Decision Sheet – Biopure Corporation Marketing Objective – Whether to launch Oxyglobin now or delay it till the approval of Hemopure. If yes‚ then devise a marketing plan for Oxyglobin. Options – 1. Launch Oxyglobin in the market immediately. 2. Defer the launch of Oxyglobin now till Hemopure release. Recommendation – Biopure Corporation should immediately launch Oxyglobin priced at $200. Rationale – Applying SWOT Analysis to the situation: Strengths 1. FDA approval has already come
Premium Blood Blood transfusion Marketing
Biopure Corporation Written Case Study I. Current Situation Audit A. Issue Oxyglobin and Hemopure are two blood substitutes that Biopure Corporation was developing. Oxyglobin was recently approved by the FDA for veterinary use while Hemapure is estimated to be approved in two years for human use. If Oxyglobin is launched it will be the first blood substitute for the veterinary market a small and price sensitive market. There is a perceived risk by Ted Jacobs‚ the VP of Human Clinical Trials
Free Blood Blood transfusion
Market Segmentation Of Pepsi At An International Level The history of Pepsi-Cola starts in 1896 in the town of New Bern in North Carolina‚ USA in a drugstore owned by the pharmacist Caleb Bradham. He came up with many recipes of new drinks to be served at the soda fountain of his drugstore. Brad ham aim was to create a drink both delicious‚ healthy‚ aiding digestion and boosting energy. It would be free of impurities and it should not contain any strong narcotics. Eventually one of his drinks became
Premium Marketing Pepsi Coca-Cola
Sport England: Segmenting the British Sports Market Introduction Sport England is the government agency responsible for building the foundations of sporting success‚ by creating a world-leading community sport environment of clubs‚ coaches‚ facilities and volunteers. They want to create a vibrant sporting culture working in partnership with national governing bodies‚ national partners‚ the HE/FE sector‚ local government‚ county sport partnerships and community organizations. Their focus is around
Premium Marketing Sport Yoga
1. a) Potential market for Humans To accurately calculate the number of units that would be required per year in the human market‚ we first estimated the total number of patients that would require RBC transfusions divided in three main groups: Elective and emergency surgeries: The current market is of 7.9 million units‚ but there is also an unserved market of borderline transfusions that would require an additional 1.5 million units (1 million surgeries with requirements of 1-2 units / surgery)
Premium Blood Organ transplant Blood transfusion
market segmentation Market segmentation is a marketing strategy that involves dividing a broad target market into subsets of consumers who have common needs (and/or common desires) as well as common applications for the relevant goods and services. Depending on the specific characteristics of the product‚ these subsets may be divided by criteria such as age and gender‚ or other distinctions‚ such as location or income. Marketing campaigns can then be designed and implemented to target these specific
Premium Marketing
Executive Summary Biopure Corporation was established in 1984 and is a privately owned pharmaceutical firm. They are trying to launch two new products: Hemopure (human market) and Oxyglobin (veterinary market). They are the only company aggressively engaged in the development of blood substitutes for the vet market. Biopure has invested $200M in the development of said blood substitutes. They currently don’t have any revenues with little to no debt and financing of $50M to support these operations
Premium Health care Net present value Medicine
Biopure Case Study Executive Summary * Biopure Corporation developed two new products to enter into the field of blood substitutes: Hemopure‚ directed to the human market and Oxyglobin‚ for the veterinary market. Through the end of 1997 no blood substitute had received approval for use anywhere in the world. * What distinguishes both products from other “hemoglobin-based” blood substitutes is the fact that they are “bovine-sourced” as opposed to “human-sourced”‚ i.e. they are derived from
Free Blood Blood transfusion
Depreciation:- accumulated depreciation is an asset‚ so it will increase with a debit. Why adjusting entries are prepared give some reasons? Answer: Adjusting entries have to be made because a company’s assets‚ expenses‚ and liabilities never stay the same from one accounting period to another. I will try to give you at least two examples of why adjusting entries must be made. Example 1. A customer purchases items on account for the amount of $500. When the sale is first made the company
Premium Depreciation Generally Accepted Accounting Principles Financial ratios